Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to MTX Therapy

NCT00611455 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

265

Enrollment

INDUSTRY

Sponsor class

Stopped Ofatumumab IV trials in RA were prematurely terminated because GSK refocused clinical development of autoimmune indications on the subcutaneous delivery.

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: ofatumumab
DRUG: Placebo

Sponsor

GlaxoSmithKline